Article metrics

Extended report
Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study

 

Online download statistics by month:

Online download statistics by month: June 2017 to December 2019

AbstractFullPdf
Jun 201796928397
Jul 2017642692201
Aug 2017412456161
Sep 2017601601190
Oct 2017470470188
Nov 2017312313123
Dec 201743943984
Jan 201835435565
Feb 201847045279
Mar 201843542961
Apr 201856356365
May 201839839962
Jun 201826126171
Jul 201829629697
Aug 201836336359
Sep 201830230271
Oct 2018422422127
Nov 2018445445146
Dec 201831131174
Jan 201928528575
Feb 201926025972
Mar 201928228275
Apr 201924924872
May 201923723667
Jun 201917217243
Jul 201917417463
Aug 201918618683
Sep 201918218069
Oct 201916716770
Nov 201916015871
Dec 201917917846
Total10125110223127